Emerging Technologies series

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.

Nissan Elimelech, founder of Augmedics, discusses the process of developing augmented reality surgical navigation technology and his next endeavor to develop the first AR glasses specifically for healthcare.

Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.

Molly Gibson, president of future science at Lila Sciences, explains how the company's superintelligence will reshape research across life, chemical and material sciences.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.

Jayme Strauss, chief commercial and clinical officer at Precision Neuroscience, joined MobiHealthNews to discuss the company's brain-computer interface aimed at allowing individuals to control digital devices using their thoughts.